Skip To Main Content
Lilly
Menu closed
Lilly
  • Account Login / Register
  • Medical Home
    • Medical Information
  • Medical Education
  • Science
Ask Lilly

We're here to help.

Chat
Chat with us Chat with us
Question Contact Us
Expand contact lilly
Lilly

You are now leaving the LillyMedical.com website

The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Lilly USA, LLC does not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to Lilly USA, LLC. Lilly USA, LLC is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.
Click "Continue" to proceed or "Return" to return to LillyMedical.com.

  1. Medical Information Right
  2. Oncology Right
  3. Alimta (pemetrexed for injection) Right
  4. ALIMTA® (pemetrexed): Mechanism of Action
Search Alimta (type in keywords)
Search Medical Information

If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)

Loading icon

Alimta ® (pemetrexed for injection)

100 mg and 500 mg vials

Full Prescribing Information

This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

ALIMTA® (pemetrexed): Mechanism of Action

Alimta (pemetrexed) is a folate analog metabolic inhibitor that disrupts folate-dependent metabolic processes essential for cell replication.

Detailed Information

Pemetrexed is a folate analog metabolic inhibitor that disrupts folate-dependent metabolic processes essential for cell replication.1

Data From In Vitro Studies

In vitro studies show that pemetrexed inhibits several folate-dependent enzymes involved in the de novo biosynthesis of thymidine and purine nucleotides including

  • TS

  • DHFR, and

  • GARFT.1

Mechanism of Action

  1. Pemetrexed is taken into cells by membrane carriers such as the reduced folate carrier and membrane folate binding protein transport systems.1

  2. Once in the cell, pemetrexed is converted to polyglutamate forms by the enzyme folylpolyglutamate synthetase.1

  3. The polyglutamate forms are retained in cells and are inhibitors of TS and GARFT.1

Enclosed Prescribing Information

ALIMTA® (pemetrexed for injection), for intravenous use, Lilly

Reference

1. Alimta [package insert]. Indianapolis, IN: Eli Lilly and Company; 2019.

Glossary

DHFR = dihydrofolate reductase

GARFT = glycinamide ribonucleotide formyltransferase

TS = thymidylate synthase 

Date of Last Review: July 20, 2020

Are you satisfied with this content?

Can't find what you're looking for? Contact us for answers to your medical questions.

  • Copyright
  • Terms of Use
  • Privacy Statement
  • Accessibility Statement
  • Sitemap

    This site is intended for US Healthcare Professionals only.

    4.0.17 02/2023 | GLOOTH00001 04/2015 | © Lilly USA, LLC 2023. All rights reserved.

    Product names listed above are trademarks or registered trademarks owned by or licensed to Eli Lilly and Company, its subsidiaries, or affiliates

    facebook twitter linkedin
    visit www.phactmi.org
    Lilly